Bio-Rad Laboratories, Inc. logo
Bio-Rad Laboratories, Inc. (BIO)
Compare

Bio-Rad Laboratories, Inc. (BIO) Price History:31.77%(TTM)

Compare

The price cagr for Bio-Rad Laboratories, Inc. (BIO) is +31.77% over the latest trailing 12-month period. The comparable SPY value is +22.92%. Year-to-date price return is -2.65%. Price CAGR uses adjusted close price history and excludes dividends.

Current Price

$297.17

+$5.86 (+2.01%)

Previous Close: $291.31

Today's Trading

Open
$294.30
Day High
$297.92
Day Low
$290.35
Volume
423.42K
Avg Volume
N/A

52-Week Position

62%

of the 52-week price range

From 52-week high
-13.39%
From 52-week low
+33.38%

52-Week Price Range

52-Week Low

$222.80

Jun 13, 2025

Current Price

$297.17

62% of range

52-Week High

$343.12

Oct 24, 2025

Low (+33.38% from current)(-13.39% from current) High

Price Returns by Period

1 Day

+2.01%

7 Days

-2.93%

30 Days

+16.85%

YTD

-2.65%

1 Year

+31.75%

vs 52W High

-13.39%

BIO Price Chart

End-of-day pricesAdvanced chart →
BIO$304.83 32.24%as of Jun 3, 2026

Long-Term Performance (CAGR)

Price CAGR (3Y)

-6.28%

Price CAGR (5Y)

-12.56%

Total Return CAGR (3Y)

-6.28%

Total Return CAGR (5Y)

-12.56%

CAGR (Compound Annual Growth Rate) shows the annualized return over the specified period. Total Return includes dividends reinvested.

Key Price Statistics

Current Price$297.17
Previous Close$291.31
Day Range$290.35 - $297.92
52-Week Range$222.80 - $343.12
Volume423.42K
Average VolumeN/A
Market Cap$8.03B
% from 52W High-13.39%
Data as of Wednesday, June 10, 2026

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.

Hercules, CA
7,700 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Norman D. Schwartz